Working on a deadline and haven’t gotten to listen. But previewed the slide deck. Anything of note? Accelerating Factor D trials? They downplayed Gali in the slide deck so it sounds like they’re not actively seeking suitors for a partnership on furthering covid research. (Maybe some black helicopter nonsense with the government and stockpiling but, if so, when are we going to see revenue and how much?) Otherwise, anything new?